Morgan Stanley Maintains Overweight on Ascendis Pharma, Raises Price Target to $204
Morgan Stanley maintains Ascendis Pharma (NASDAQ:ASND) with a Overweight and raises the price target from $197 to $204.
Wells Fargo Maintains Equal-Weight on Williams-Sonoma, Raises Price Target to $195
Wells Fargo analyst Zachary Fadem maintains Williams-Sonoma (NYSE:WSM) with a Equal-Weight and raises the price target from $180 to $195.
Wells Fargo Maintains Overweight on Ulta Beauty, Raises Price Target to $430
Wells Fargo analyst Ike Boruchow maintains Ulta Beauty (NASDAQ:ULTA) with a Overweight and raises the price target from $375 to $430.
Wells Fargo Maintains Overweight on UDR, Raises Price Target to $57
Wells Fargo analyst Tammi Fique maintains UDR (NYSE:UDR) with a Overweight and raises the price target from $53 to $57.
Wells Fargo Maintains Underweight on Retail Opportunity, Raises Price Target to $17
Wells Fargo analyst Tammi Fique maintains Retail Opportunity (NASDAQ:ROIC) with a Underweight and raises the price target from $16 to $17.
Wells Fargo Maintains Overweight on Public Service Enterprise, Raises Price Target to $75
Wells Fargo analyst Neil Kalton maintains Public Service Enterprise (NYSE:PEG) with a Overweight and raises the price target from $74 to $75.
Wells Fargo Maintains Underweight on Prospect Capital, Raises Price Target to $6.5
Wells Fargo analyst Finian O'Shea maintains Prospect Capital (NASDAQ:PSEC) with a Underweight and raises the price target from $6 to $6.5.
Wells Fargo Maintains Equal-Weight on NetApp, Raises Price Target to $87
Wells Fargo analyst Aaron Rakers maintains NetApp (NASDAQ:NTAP) with a Equal-Weight and raises the price target from $75 to $87.
Wells Fargo Maintains Equal-Weight on Essex Property Trust, Raises Price Target to $323
Wells Fargo analyst Tammi Fique maintains Essex Property Trust (NYSE:ESS) with a Equal-Weight and raises the price target from $300 to $323.
Wells Fargo Maintains Equal-Weight on Equity Residential, Raises Price Target to $84
Wells Fargo analyst Tammi Fique maintains Equity Residential (NYSE:EQR) with a Equal-Weight and raises the price target from $77 to $84.